SEARCH

SEARCH BY CITATION

References

  • 1
    Yu SZ. Primary liver cell cancer. In: Shanghai First Medical College, Wuhan Medical College, editors. Epidemiology, ed. 1 [in Chinese]. Beijing: People's Health Press, 1981: 476.
  • 2
    Zhu WN. Primary carcinoma of the liver. In: Shanghai First Medical College, Zhongshan Medical College, editors. Internal medicine, ed. 1 [in Chinese]. Beijing: People's Health Press, 1979: 40612.
  • 3
    Yeh FS. Liver cell cancer in Guangxi[in Chinese]. Guangxi Med J 1984; 6: 22538.
  • 4
    Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989; 49: 25069.
  • 5
    Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988; 61: 194256.
  • 6
    Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van Der Watt JJ, Vincent TJ, Purchase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985; 51: 71326.
  • 7
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 35962.
  • 8
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 3624.
  • 9
    Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 10046.
  • 10
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 10068.
  • 11
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Katayama K, Fusamoto H, et al. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992 37: 652.
  • 12
    Nishioka K. Hepatocellular carcinoma: epidemiological comparison with HBV infection [in Japanese]. Kan Tan Sui 1992; 24: 7381.
  • 13
    Ducreux M, Buffet C, Dussaix E, Pelletier G, Briantais MJ, Yvart J, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990; 335: 301.
  • 14
    Hasan F, Jeffers LJ, De Medina M, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 58991.
  • 15
    Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 8734.
  • 16
    Dazza MC, Meneses LV, Girard PM, Villaroel C, Brechot C, Larouze B. Hepatitis C virus antibody and hepatocellular carcinoma. Lancet 1990; 335: 1216.
  • 17
    Al Karawi MA, Shariq SEl Shiekh Mohamed AR, Saeed AA, Ahmed AMM. Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia. J Gastroenterol Hepatol 1992; 7: 2379.
  • 18
    Tao QM, Wang Y, Wang H, Chen WR, Sun Y, Meng Q, et al. Seroepidemiology of HCV and HBV infection in northern China. Gastroenterol Jpn 1991; 26(Suppl 3): 1568.
  • 19
    Park YM, Kim IS, Lee CD, Kim BS. Seroprevalence of antibody against hepatitis C virus (anti-HCV) in various groups of individuals in Korea. Gastroenterol Jpn 1991; 26(Suppl 3): 15963.
  • 20
    Sulaiman HA, Noer HMS, Endardjo S, Hoyaranda E. The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarata, Indonesia. Gastroenterol Jpn 1991; 26(Suppl 3): 17983.
  • 21
    Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 56215.
  • 22
    Lee SD, Lee FY, Wu JC, Hwang SJ, Wang SS, Lo KJ. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992; 69: 3425.
  • 23
    Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area: a case-control study. Cancer 1992; 69: 20524.
  • 24
    Leung NWY, Tam JS, Lai JY, Leung TWT, Lau WY, Shiu W, et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 1992; 70: 404.
  • 25
    Ramesh R, Munshi A, Panda SK. Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 1992; 7: 3935.
  • 26
    Lok ASF, Ma OCK, Chen TM, Lai CL, Chung HT, Ng CPL, et al. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology 1991; 14: 75662.
  • 27
    McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 7547.
  • 28
    Wu XS, Mizokami M, Fang ZX, Zhang XN, Zhang LY, Suzuki K, et al. Prevalence of hepatitis C virus infection among liver diseases in Nanjing at China [in Japanese]. Acta Hepatol Jpn 1992; 33: 9856.
  • 29
    Ishiguro N, Tomimatsu M, Nagahara H, Obata H. Clinical evaluation of a newly established anti-HCV assay for the diagnosis of hepatitis C in Japan. J Gastroenterol Hepatol 1992; 7: 6027.
  • 30
    Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16: 3005.